(Q46747793)

English

Simultaneous staining of sputum smears for acid-fast and lipid-containing Myobacterium tuberculosis can enhance the clinical evaluation of antituberculosis treatments

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/26318558

Simultaneous staining of sputum smears for acid-fast and lipid-containing Myobacterium tuberculosis can enhance the clinical evaluation of antituberculosis treatments (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/26318558

0 references

1 reference

based on heuristic

inferred from title

author name string

Xavier A Kayigire

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/26318558

Sven O Friedrich

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/26318558

Lize van der Merwe

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/26318558

Peter R Donald

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/26318558

Andreas H Diacon

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/26318558

publication date

13 August 2015

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/26318558

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/26318558

95

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/26318558

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/26318558

770-779

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/26318558

TREATMENT OF STAPHYLOCOCCAL INFECTIONS WITH PENICILLIN BY INTERMITTENT STERILISATION

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Stationary phase gene expression of Mycobacterium tuberculosis following a progressive nutrient depletion: a model for persistent organisms?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Nonreplicating persistence of mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Stability of DNA Patterns and Evidence ofMycobacterium tuberculosisReactivation Occurring Decades after the Initial Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Hypoxia: a window into Mycobacterium tuberculosis latency

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Gene expression of Mycobacterium tuberculosis putative transcription factors whiB1-7 in redox environments.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

M. tuberculosis persistence, latency, and drug tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Persister populations of Mycobacterium tuberculosis in sputum that grow in liquid but not on solid culture media

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Formation of 'non-culturable' cells of Mycobacterium smegmatis in stationary phase in response to growth under suboptimal conditions and their Rpf-mediated resuscitation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Resuscitation-promoting factors reveal an occult population of tubercle Bacilli in Sputum.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Cell-wall alterations as an attribute of Mycobacterium tuberculosis in latent infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Intracellular lipophilic inclusions of mycobacteria in vitro and in sputum

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

The early bactericidal activity of antituberculosis drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

The early bactericidal activity of anti-tuberculosis drugs: a literature review

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

High-dose rifapentine with moxifloxacin for pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

A four-month gatifloxacin-containing regimen for treating tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Dormant forms of Mycobacterium smegmatis with distinct morphology.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Dormant ovoid cells of Mycobacterium tuberculosis are formed in response to gradual external acidification

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Visualizing samples with box plots

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Persisters, persistent infections and the Yin-Yang model

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Microbial phenotypic heterogeneity and antibiotic tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Why is long-term therapy required to cure tuberculosis?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Pharmacodynamic Modeling of Bacillary Elimination Rates and Detection of Bacterial Lipid Bodies in Sputum to Predict and Understand Outcomes in Treatment of Pulmonary Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Rapid evaluation in whole blood culture of regimens for XDR-TB containing PNU-100480 (sutezolid), TMC207, PA-824, SQ109, and pyrazinamide

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Arrested protein synthesis increases persister-like cell formation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

The Influence of Adverse Conditions upon the Respiratory Metabolism and Growth of Human Tubercle Bacilli

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.001

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.TUBE.2015.08.001

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/26318558

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/26318558

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46747793&oldid=2129642720"